MIND Diet for Breast Cancer
(MIND-TNBC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether a specific healthy eating plan, the MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay), can reduce "chemobrain" and other symptoms like fatigue and anxiety in women with stage II-III triple-negative breast cancer undergoing chemotherapy. Participants will be divided into two groups: one will follow the MIND diet, while the other will receive general health advice, with an opportunity to try the MIND diet later. This trial may suit women recently diagnosed with this type of breast cancer who are about to start or have recently started chemotherapy and can access the internet for virtual sessions. As an unphased trial, it offers a unique opportunity to explore the potential benefits of the MIND diet for improving quality of life during chemotherapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on diet and does not mention medication changes.
Is there any evidence suggesting that the MIND eating plan is safe for women with breast cancer?
Research has shown that the MIND eating plan, which combines elements of the Mediterranean and DASH diets, is generally safe and easy to follow. This diet emphasizes nutritious, plant-based foods like leafy greens, nuts, and berries. Studies have found that people who adhere to this diet have a significantly lower risk of developing breast cancer.
The MIND diet has also been used in other studies to enhance brain health without causing major side effects. This suggests it could be a safe option for those looking to reduce memory and thinking problems related to cancer treatment. Although specific information on side effects from these studies is limited, the diet's focus on healthy foods supports its safety.12345Why are researchers excited about this trial?
Researchers are excited about the MIND Eating Plan for breast cancer because it takes a unique approach by focusing on dietary habits rather than traditional medical treatments like chemotherapy or hormone therapy. The MIND diet combines aspects of the Mediterranean and DASH diets, emphasizing foods that may support brain health and reduce inflammation, which could have potential benefits for cancer patients. Unlike conventional treatments, this plan offers a non-invasive option that integrates lifestyle changes, allowing patients to take an active role in their treatment and potentially improving overall well-being. Additionally, the use of wearable technology like Fitbits helps track physical activity, providing valuable data on how lifestyle modifications impact health outcomes.
What evidence suggests that the MIND eating plan might be an effective treatment for cancer-related cognitive impairment?
Research has shown that the MIND diet, which combines elements of the Mediterranean and DASH diets, may slow memory and thinking problems. Studies have found that people who follow the MIND diet tend to experience fewer memory and thinking issues as they age. Additionally, women who adhere to the MIND diet are less likely to develop breast cancer. This trial will compare two groups: one group will receive MIND diet counseling, focusing on nutritious, plant-based foods like leafy greens, nuts, and berries, which benefit brain health. The other group will receive general health recommendations. These findings suggest that the MIND diet may improve mental function and reduce "chemobrain" symptoms in women undergoing breast cancer treatment.12367
Who Is on the Research Team?
Tonya Orchard, PhD
Principal Investigator
Ohio State University Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for women aged 40-65 with newly diagnosed stage II-III triple negative breast cancer, who are about to start or have started chemotherapy within the last 6 months. Participants must be able to use internet resources and video calls for remote sessions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either MIND diet counseling or general health recommendations over 12 weeks, with virtual sessions and dietary interventions.
Follow-up
Participants are monitored for sustainability of dietary changes and outcome measures 6 months post-intervention.
Open-label extension (optional)
Participants initially in the general health recommendations group may opt into the MIND diet intervention after the 6-month follow-up.
What Are the Treatments Tested in This Trial?
Interventions
- MIND Eating Plan
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University Comprehensive Cancer Center
Lead Sponsor
American Institute for Cancer Research
Collaborator